Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8383099 Adoptive cell therapy with young T cells

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
August 26, 2010
0
Date of Patent
February 26, 2013
0
Patent Application Number
12869390
0
Patent Citations Received
‌
US Patent 12123021 Gene-regulating compositions and methods for improved immunotherapy
0
‌
US Patent 12024718 Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
0
‌
US Patent 12084682 Gene-regulating compositions and methods for improved immunotherapy
0
‌
US Patent 12104172 Processes for generating TIL products enriched for tumor antigen-specific t-cells
0
‌
US Patent 12110506 Method for culturing tumor infiltrating lymphocytes
0
‌
US Patent 12121541 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
0
‌
US Patent 11667692 T cell receptors recognizing HLA-CW8 restricted mutated KRAS
0
‌
US Patent 11697676 Anti-human papillomavirus 16 E6 T cell receptors
0
‌
US Patent 11713446 Processes for generating TIL products enriched for tumor antigen-specific T-cells
0
‌
US Patent 11767510 Devices and methods for isolating tumor infiltrating lymphocytes and uses thereof
•••
Patent Inventor Names
Mark E. Dudley
0
Steven A. Rosenberg
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
8383099
0
Patent Primary Examiner
‌
Michail Belyavskyi
0

Find more entities like US Patent 8383099 Adoptive cell therapy with young T cells

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo